Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Marshall S. Stanton"'
Publikováno v:
Pacing and Clinical Electrophysiology. 23:842-846
Subcutaneous leads (SQ) add complexity to the defibrillation system and the implant procedure. New low output devices might increase the requirement for SQ arrays, although this might be offset by the effects of active can and biphasic technology. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64adf39fcd7c1acca628b5e4337a288e
https://doi.org/10.1111/j.1540-8159.2000.tb00853.x
https://doi.org/10.1111/j.1540-8159.2000.tb00853.x
Autor:
Gregory K. Bell, Marshall S. Stanton
Publikováno v:
Circulation. 101:1067-1074
Background —We reviewed the literature pertaining to the cost-effectiveness of implantable cardioverter-defibrillator (ICD) therapy in the management of ventricular fibrillation and tachycardia. Discussed are the methodology, advantages, and limita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1fa26fbe614cb1789c500fa83894db
https://doi.org/10.1161/01.cir.101.9.1067
https://doi.org/10.1161/01.cir.101.9.1067
Autor:
Stefano Favale, James P. Daubert, Adrian K. Almquist, Robert F. Rea, Barry J. Maron, Paolo Spirito, N.A. Mark Estes, Gust H. Bardy, Sandro Betocchi, Mark S. Link, Andrew E. Epstein, Marshall S. Stanton, Susan A. Casey, Win Kuang Shen, Giuseppe Boriani
Publikováno v:
New England Journal of Medicine. 342:365-373
Hypertrophic cardiomyopathy is a genetic disease associated with a risk of ventricular tachyarrhythmias and sudden death, especially in young patients.We conducted a retrospective multicenter study of the efficacy of implantable cardioverter-defibril
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c85e5275feea579fbc27e6d07b3b1555
https://doi.org/10.1056/nejm200002103420601
https://doi.org/10.1056/nejm200002103420601
Autor:
M R N Jane Trusty, David M. Luria, Michal Benderly, Paul A. Friedman, Stephen C. Hammill, Marshall S. Stanton, Michael Glikson
Publikováno v:
Journal of Cardiovascular Electrophysiology. 11:127-135
Routine Arrhythmia Inductions in Patients with ICDs. Introduction: The value of ventricular arrhythmia inductions as part of routine implantable cardioverter defibrillator (ICD) follow-up in new-generation pectoral ICDs is unknown Methods and Results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58a9c61f428cc8f69376923eb8e0c0f1
https://doi.org/10.1111/j.1540-8167.2000.tb00311.x
https://doi.org/10.1111/j.1540-8167.2000.tb00311.x
Autor:
Stephen C. Hammill, Marshall S. Stanton, Suellen Grice, Michael Glikson, David L. Hayes, Jane M. Trusty
Publikováno v:
The American Journal of Cardiology. 83:360-366
Current use of newer implantable cardioverter-defibrillators (ICDs) has changed the spectrum of pacemaker–ICD interactions and provided new tools for testing and understanding those interactions. Testing for pacemaker–ICD interactions was perform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4372c188e1debf7504ea766c59a8ebaa
https://doi.org/10.1016/s0002-9149(98)00869-8
https://doi.org/10.1016/s0002-9149(98)00869-8
Autor:
Marshall S. Stanton, Antonio Pacifico, Robert Gabler, Timothy R. Church, James W. Johnson, David M. Steinhaus, Philip D. Henry
Publikováno v:
The American Journal of Cardiology. 82:875-880
The Jewel 7219D was the first non-thoracotomy implantable cardioverter-defibrillator (ICD) with biphasic shock capability small enough to be placed in the prepectoral subcutaneous position. Size reduction of ICDs is desirable, but safety and efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6407bf523133f03d3bdbe56bc173aed1
https://doi.org/10.1016/s0002-9149(98)00495-0
https://doi.org/10.1016/s0002-9149(98)00495-0
Publikováno v:
Pacing and Clinical Electrophysiology. 21:339-351
Most patients with implantable defibrillators have diminished cardiac function. Progressive heart failure might impair defibrillation efficacy, leading to interpreted device, failure. This study sought to determine the effect of ventricular dysfuncti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a18fd29576f2fcdfe8a76cc2753e9520
https://doi.org/10.1111/j.1540-8159.1998.tb00058.x
https://doi.org/10.1111/j.1540-8159.1998.tb00058.x
Publikováno v:
ACC Current Journal Review. 6:16-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5151f0ff83717094172f19ea037271f6
https://doi.org/10.1016/s1062-1458(97)00045-7
https://doi.org/10.1016/s1062-1458(97)00045-7
Publikováno v:
New England Journal of Medicine. 336:1429-1434
Atrial tachyarrhythmias early in the recovery period after cardiothoracic surgery are common; they develop in 11 to 40 percent of patients after coronary-artery bypass grafting1–3 and in over 50 percent of patients after valvular surgery.2 Technica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0245065af31dabd7490121e95f4bb2ba
https://doi.org/10.1056/nejm199705153362006
https://doi.org/10.1056/nejm199705153362006
Publikováno v:
Journal of the American College of Cardiology. 28(2):423-427
Objectives. This study was designed to determine the susceptibility of an implanted cardioverter-defibrillator to electromagnetic interference in an electrically hostile work site environment, with the ultimate goal of allowing the patient to return
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::accccb72023461aa083a36157ad396d8